Lymph-Vascular Invasion



Lymph-Vascular Invasion










LVI is the presence of tumor emboli within lymphatic spaces image that are typically associated with small arterioles image and veins image. The presence of LVI is associated with lymph node metastases and recurrence.






The diagnosis of LVI image is made easier by recognizing the normal microanatomy. Lymphatic spaces are typically present within the interlobular septae adjacent to small arterioles image.


TERMINOLOGY


Abbreviations



  • Lymph-vascular invasion (LVI)


Synonyms



  • Lymphatic/vascular invasion


  • Lymphovascular invasion


  • Vascular invasion


Definitions



  • Tumor emboli within peritumoral vascular channels (lymphatics and capillaries)


EPIDEMIOLOGY


Incidence



  • Reported to be present in 10-90% of invasive breast carcinomas


  • Incidence varies with patient population and diagnostic criteria


CLINICAL IMPLICATIONS


Clinical Risk Factors



  • Pathologic factors and risk



    • Breast carcinomas metastasize via both lymphatics and blood vessels


    • Lymphatic channels are main route for metastasis (in approximately 2/3 of cancers)



      • LVI is associated with the presence of lymph node metastases


    • In a subset of breast carcinomas, metastasis is via blood vessels



      • Not associated with lymph node metastasis


      • Fewer vessels are involved, and tumor emboli are smaller than those in lymphatics


      • Approximately 20-30% of node-negative patients develop distant metastases, presumably due to blood vessel invasion


      • Spindle cell carcinomas, phyllodes tumors, and angiosarcomas are examples of tumors that rarely involve lymph nodes


      • May be specific molecular signatures associated with pattern of metastasis


    • Difficult to distinguish lymphatics from small capillaries



      • Immunoperoxidase markers cannot always identify type of vessel with confidence


      • Many patients have both lymphatic and blood vessel involvement


      • For practical purposes, no need to distinguish lymphatic from capillary to diagnose LVI


    • Peritumoral LVI has independent prognostic significance



      • Associated with increased risk of axillary lymph node metastasis as well as local and distant recurrence


    • Intratumoral LVI likely has little or no prognostic significance



      • Difficult to distinguish LVI within confines of invasive carcinoma from retraction artifact


      • Tumor in vascular channels that has not traveled beyond the tumor is less likely to be prognostically significant


      • Not associated with lymph node metastasis


      • Recommended that intratumoral LVI alone not be reported


    • LVI is more frequently associated with breast cancers demonstrating other aggressive features



      • High Ki-67 score


      • High histologic grade


      • Absence of hormone receptor expression


  • Prognostic factors and risk



    • LVI is associated with significantly increased risk for tumor recurrence or death independent of axillary node status




      • Recurrence for stage I (node-negative) invasive breast cancer increases from 22% without LVI to 38% with LVI


      • Presence of LVI increases risk for metastases in additional nodes if sentinel node is positive


      • LVI may be associated with resistance to chemotherapy


Therapeutic Implications



  • LVI is useful in therapeutic decision making, particularly for node-negative patients with small cancers


MICROSCOPIC FINDINGS


General Features



  • Strict criteria for LVI aid in making correct diagnosis


  • LVI should be assessed at periphery, beyond advancing border of invasive carcinoma



    • Majority of LVI will be within 1-2 mm of edge of invasive carcinoma


    • If foci are only seen at greater distance, they are more likely to be artifactual


  • Tumor emboli should be within vascular channels lined by a single layer of endothelial cells



    • Nuclei of endothelial cells are not always apparent in all spaces


    • Lymphatics and small capillaries are not surrounded by muscular layer or elastica



      • Red blood cells may be present in either structure


    • Large arteries or veins with muscular walls are rarely involved



      • Larger vessels can be identified with elastic stains


      • Elastin fibers are also present surrounding ducts and should not be mistaken for blood vessels


      • IHC for smooth muscle markers is also helpful for identifying larger vessels


  • Tumor emboli usually do not completely conform to shape of space



    • If space is completely filled by tumor cells, it is difficult to recognize as LVI


    • Tumor cells within a larger space of different shape favors LVI



      • In retraction artifact, shape of tumor and space are usually identical


    • Spaces may be elongated and sinusoidal as lymphatic passes in and out of plane of section


    • Branch points (Y-shaped focus) are more likely to be due to LVI than invasive carcinoma


  • Recognizing anatomic distribution of lymphatics aids in their identification



    • Lymphatics and small blood vessels usually run together between lobules


    • Lymphatics are often seen adjacent to small arteriole and vein


    • Lymphatics may cup around arteriole


Immunohistochemistry



  • Can be used to identify endothelial cells



    • Clinical significance of LVI detected only by IHC and not seen after careful review of H&E sections remains unclear


  • CD31 and CD34 are positive in endothelial cells



    • CD31 is predominantly positive in blood vessels


    • CD34 is positive in blood vessels and also in some lymphatics


    • CD34 is also positive in stromal cells, which limits its usefulness for distinguishing LVI from retraction artifact


  • Podoplanin is a mucin-type transmembrane glycoprotein 1st described in lymphatic endothelial cells



    • Monoclonal antibody D2-40 (against podoplanin) selectively detects lymphatic vessels



      • Most sensitive and specific marker for lymphatic endothelial cells


      • Pattern should be strong and linear


      • Endothelial cells of arteries, veins, and capillaries should not be positive


      • Myoepithelial cells can be positive for D2-40; therefore, not very useful to distinguish DCIS from LVI


      • Pattern in myoepithelial cells is often weak, granular, and membranous


    • Use of D2-40 can increase number of foci of LVI detected by 20% over H&E sections alone


    • D2-40 may also be positive in basal-like carcinomas, squamous cell carcinomas, and angiosarcomas



      • Use of this marker to evaluate LVI in these tumor types may be more difficult


Positive Lymph Node in Absence of LVI



  • Usually occurs when there is 1 or only a few positive lymph nodes


  • Frequently occurs with discohesive (e.g., lobular) carcinomas



    • Cohesive carcinomas grow as contiguous plugs of tumor within lymphatics with adhesion to vessel wall


    • Discohesive carcinomas are present as dispersed cells, not adherent to wall, and may only be present transiently


  • In some cases, extensive LVI can be mistaken for DCIS


  • Diagnosis of LVI should not be made based only on presence of lymph node metastases


Negative Lymph Nodes in Presence of LVI



  • LVI may be present although no metastases are present in lymph nodes



    • Reported in 5-10% of node-negative carcinomas


  • Lymphatic drainage may be toward internal mammary nodes, particularly for medially located carcinomas


  • Metastatic foci may not have reached axillary nodes or may not be able to establish viable growth in nodes


DIFFERENTIAL DIAGNOSIS


DCIS

Jul 6, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Lymph-Vascular Invasion

Full access? Get Clinical Tree

Get Clinical Tree app for offline access